CRISPR Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
-Enrollment ongoing in clinical trials of CTX001™ for patients with severe hemoglobinopathies--Enrollment ongoing in clinical trial of CTX110™, targeting CD19+ […]